Table 1.
Ref. | Methods | Predictive markers | Risk factors of severe skin toxicity |
Jatoi et al[39] (2009) | Patient's backgrounds | Age | Younger |
Gender | Men | ||
Graziano et al[40] (2008) | EGFR polymorphism | CA repeat in EGFR intron-1 | EGFR intron-1 S/S variant |
Vallböhmer et al[42] (2005) | mRNA expression | Cox-2 | Low expression |
Takahashi et al[43,44] (2014, 2015) | Serum levels of ligands | AREG, EREG, HGF | Low levels of ligands at pre-treatment |
EGFR: Epidermal growth factor receptor; Cox-2: Cyclo-oxygenase 2; AREG: Amphilegulin; EREG: Epiregulin; HGF: Hepatocyte growth factor.